Alys Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi.
Alys Pharmaceuticals has raised $100M across 1 funding round on record, the most recent a Seed of $100M announced in Feb 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alys Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Alys Pharmaceuticals Funding Rounds
Alys Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Alys Pharmaceuticals Funding Compared to Other Biotechnology Startups
Alys Pharmaceuticals' latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alys Pharmaceuticals in Biotechnology and Boston
Companies Similar to Alys Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Alys Pharmaceuticals Funding FAQs
What does Alys Pharmaceuticals do?
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi.
How much funding has Alys Pharmaceuticals raised?
Alys Pharmaceuticals has raised $100M across 1 round on record. The most recent is a Seed of $100M announced in Feb 2024.
When did Alys Pharmaceuticals last raise funding?
Alys Pharmaceuticals' most recent funding round on record is a Seed of $100M, announced in Feb 2024.
Who founded Alys Pharmaceuticals?
FundedIQ lists John Harris (Founder) at Alys Pharmaceuticals.
Where is Alys Pharmaceuticals headquartered?
Alys Pharmaceuticals is based in Boston, Massachusetts, United States.
How many employees does Alys Pharmaceuticals have?
Alys Pharmaceuticals is in the 11-50 employee band.
How does Alys Pharmaceuticals' funding compare to other Biotechnology startups?
Alys Pharmaceuticals' latest round of $100M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Alys Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alys Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.